Market Cap | ₹21,869Cr |
ROE | 22.72% |
P/E Ratio(TTM) | 119.27 |
EPS(TTM) | 73.34 |
P/B Ratio | 28.39 |
Dividend Yield | 0.37% |
Industry P/E | 40.64 |
Book Value | 308.14 |
Debt to Equity | 0.05 |
Face Value | 2 |
Parent Organisation | Astrazeneca Pharma India |
Managing Director | Mr. Sanjeev Panchal |
NSE Symbol | ASTRAZEN |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Abbott India | NA (0.00%) | 44.26 | ||
GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 49.20 | ||
Pfizer | NA (0.00%) | 28.40 | ||
Sanofi Consumer Healthcare India | NA (0.00%) | 58.19 |